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Introduction: Nerve growth factor (NGF) has an important role in the generation of discogenic pain. We
hypothesized that annular rupture is a trigger for discogenic pain through the action of NGF. In this study, the
protein levels of NGF in discs from patients with disc herniation were examined and compared with those from
discs of patients with other lumbar degenerative disc diseases.
Methods: Patients (n = 55) with lumbar degenerative disc disease treated by surgery were included. Nucleus
pulposus tissue (or herniated disc tissue) was surgically removed and homogenized; protein levels were quantified
using an enzyme-linked immunosorbent assay (ELISA) for NGF. Levels of NGF in the discs were compared
between 1) patients with herniated discs (herniated group) and those with other lumbar degenerative disc diseases
(non-herniated group), and 2) low-grade and high-grade degenerated discs. Patient’s symptoms were assessed
using a visual analog scale (VAS) and the Oswestry disability index (ODI); the influence of NGF levels on pre- and
post-operative symptoms was examined.
Results: Mean levels of NGF in discs of patients were significantly higher in herniated discs (83.4 pg/mg total
protein) than those in non-herniated discs (68.4 pg/mg).
No significant differences in levels of NGF were found between low-grade and high-grade degenerated discs.
Multivariate analysis, adjusted for age and sex, also showed significant correlation between the presence of disc
herniation and NGF levels, though no significant correlation was found between disc degeneration and NGF levels.
In both herniated and non-herniated groups, pre-operative symptoms were not related to NGF levels. In the
herniated group, post-operative lower extremity pain and low back pain (LBP) in motion were greater in patients
with low levels of NGF; no significant differences were found in the non-herniated group.
Conclusions: This study reports that NGF increased in herniated discs, and may play an important role in the
generation of discogenic pain. Analysis of patient symptoms revealed that pre-operative NGF levels were related to
post-operative residual lower extremity pain and LBP in motion. The results suggest that NGF in the disc is related
to pain generation, however, the impact of NGF on generation of LBP varies in individual patients.* Correspondence: yasuaoki35@fc4.so-net.ne.jp
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Despite its clinical importance, the pathogenesis of dis-
cogenic pain is poorly understood. Disc degeneration is
thought to be one of the causes of chronic discogenic
low back pain (LBP) [1]. However, the development of
magnetic resonance imaging (MRI) has revealed that disc
degeneration is commonly observed in patients without
LBP, suggesting that the correlation between disc dege-
neration and pain is not clear [2-4].
It has been reported that intradiscal injections of local
anesthetics and steroids eliminate acute LBP in patients
with a radial annular tear; this suggests an annular rup-
ture is one of the causes of acute LBP [5]. Acute dis-
cogenic LBP frequently disappears within one to two
weeks. One possible explanation for the favorable clin-
ical course is that an annular rupture usually heals spon-
taneously. Clinically, chronic discogenic pain is often
preceded by one or more attacks of acute discogenic
LBP [6]. These observations raise the possibility that
acute LBP can be a trigger for development of chronic
discogenic LBP.
Generally, the lumbar intervertebral disc has a high
threshold to mechanical stimuli [7] and lacks sensory
nerve fibers in the inner layer of the discs [8,9], suggest-
ing the lumbar disc is relatively insensitive to nociceptive
stimuli under normal conditions. Previous studies using
animal models show that annular rupture promotes (i)
nerve ingrowth [10-12], (ii) an increase of inflamma-
tory mediators [13,14], and (iii) sensitization of nerve
fibers in the disc [15], all of which are thought to cause
chronic discogenic LBP in the human [9,16-18]. These
results support the hypothesis that annular rupture can
be a trigger initiating development of chronic disco-
genic LBP.
Our previous studies show that disc-innervating neu-
rons have extremely high sensitivity to nerve growth fac-
tor (NGF) [19,20]. NGF has sensitizing and neurotrophic
effects on the sensory nervous system, and has an im-
portant role in the generation of inflammatory pain
states [21-23]. Therefore, we propose that NGF may act
as a key factor in the generation of discogenic pain
[19,24].
Abe et al. reported that nucleus pulposus cells isola-
ted from human discs express and synthesize NGF [25].
Freemont et al. revealed that NGF is present in painful,
but not in asymptomatic, human discs [26]. Purmessur
et al. demonstrated the localized expression of NGF by
the fibroblast-like cells of human discs by immunohisto-
chemistry [27]. Richardson et al. found increased expres-
sion of NGF mRNA in human discs from patients with
chronic LBP, using quantitative real-time polymerase
chain reaction [28]. From these observations, it is known
that NGF is synthesized in the disc and may be related to
the difference between asymptomatic and painful discs.Therefore, we hypothesize that NGF is upregulated
following annular rupture and may induce pathological
changes, such as nerve ingrowth and sensitization, in the
disc. If the upregulation persists, the disc becomes a
source of chronic discogenic pain. To test this hypo-
thesis, we first examined protein levels of NGF in discs
from patients with disc herniation, and compared these
levels with those in discs from patients with other lum-
bar degenerative diseases without disc herniation. Then
we assessed the correlation between protein levels of
NGF and disc degeneration. Finally, the correlation be-
tween protein levels of NGF and patient low back and
lower extremity symptoms were examined.
Methods
Fifty-five patients with lumbar degenerative disease, who
received lumbar surgery in which a lumbar interverte-
bral disc was resected, were included in this study. Sur-
gery for lumbar degenerative disease is routine clinical
practice in our hospital. We surgically obtained 59 discs
from patients with disc herniation (29 discs from 29 pa-
tients), or patients with other degenerated disc diseases
(30 discs from 26 patients), such as spondylolisthesis,
spinal canal stenosis, and lumbar degenerative scoliosis,
and these were stored at −20°C. All the resected discs
were evaluated using MRI; the Pfirmann grading was used
to score disc degeneration from grade 1 (non-degenerated
disc) to grade 5 (severely degenerated disc) [29]. Written
informed consent was obtained prior to surgery. The
study protocol was approved by the institutional ethics
committee of Toho University Sakura Medical Center
(number 2012-072).
Evaluation of clinical symptoms in patients
Patient symptoms were assessed by visual analog scale
(VAS) and Oswestry disability index (ODI). Pre-operative
VAS scores (0 to 100 mm, for LBP, lower-extremity pain,
and lower-extremity numbness) and the ODI were evalu-
ated before surgery. In addition, our originally developed
detailed VAS scoring system for LBP in motion, standing,
and sitting [30] was used for a detailed evaluation of LBP.
Postoperative data were prospectively acquired at one year
following surgery.
Measurement of NGF in the surgical samples
Nucleus pulposus tissue (or herniated disc tissue) was
surgically removed and homogenized. Total protein was
extracted with a Qproteome mammalian protein prep
kit in accordance with the instructions of the manu-
facturer (Qiagen Inc., Valencia, CA, USA). Protein levels
were quantified using a commercially available ELISA
for beta-NGF (DY256, R&D Systems, Minneapolis, MN,
USA). All samples were measured in duplicate, and the
mean of the duplicate levels was used for statistical
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normalized by the total protein concentration measured
using the bicinchoninic acid (BCA) protein assay me-
thod (Pierce, Rockford, IL, USA).
Evaluation of disc NGF levels and clinical data
Levels of NGF in the discs were compared between her-
niated discs (herniated group) and discs with other lum-
bar degenerative disc diseases (non-herniated group). In
each group, discs were divided into two subgroups by
the degree of disc degeneration: Pfirmann grades 2 to 3
(low-grade degeneration) versus Pfirmann grades 4 to 5
(high-grade) in the herniated group and Pfirmann grades
3 to 4 (low-grade degeneration) versus Pfirmann grade 5
(high-grade) in the non-herniated group. In each group,
NGF levels in the discs were then compared between
discs with low-grade and high-grade degeneration.
To investigate the relative influence of disc herniation,
age, sex, and disc degeneration, the correlation of NGF
levels with the presence of disc herniation, age, sex, and
degree of disc degeneration was assessed. For compari-
son of patient symptoms, only data from patients with a
single-level lumbar disc disorder without pathological
changes in the other levels were used (herniated group:
n = 24; non-herniated group: n = 12). The patients in
each group were divided into two subgroups (low-NGF
group and high-NGF group) according to NGF levels di-
vided by median values, and the pre-operative VAS score,
ODI and detailed VAS scores were compared between
these two subgroups.
For the comparison of postoperative symptoms also,
only data from patients with a single-level lumbar disc
disorder were used. Patients who had factors affecting
surgical results, such as post-surgical complication and
recurrence of disc herniation, were excluded. In the her-
niated group, most patients were treated by decompres-
sion surgery without fusion, although some patients
were treated by lumbar interbody fusion. However, only
patients treated by decompression surgery were included
for the analysis of postoperative data (n = 17). In the
non-herniated group, all patients were treated by fusion
surgery and were included for the analysis of postopera-
tive data.
Statistical analysis
For statistical analyses we used the unpaired t-test for
NGF levels, age, and VAS scores, the Mann-Whitney
U-test for ODI, and the chi-square test for sex and disc
degeneration. Pearson’s correlation coefficient was used to
analyze the correlation of NGF with age, and Spearman’s
rank correlation coefficient was used to analyze the cor-
relation of NGF with disc herniation, sex, and disc dege-
neration. Multiple linear regression analysis was used to
investigate the relative influences of disc herniation anddisc degeneration on NGF level in the discs, after adjust-
ing for age and sex. Probability values <0.05 were consid-
ered significant. Values are expressed as the mean ± SD.
Results
Comparison of NGF levels between herniated discs and
non-herniated discs
Mean levels of NGF in discs of patients were 83.4 ± 37.7
pg/mg total protein in the herniated group and 64.8 ±
25.9 pg/mg total protein in the non-herniated group.
The herniated group showed significantly higher levels
of NGF (Figure 1; P = 0.031).
The pre-operative characteristics of the patients in
each group are shown in Additional file 1: Table S1. The
mean patient age was significantly younger, and the
grade of disc degeneration was significantly lower in the
herniated group (Additional file 1: Table S1; P <0.01).
Comparison of NGF levels between discs with low-and
high-grade degeneration
In the herniated group, mean disc levels of NGF were
80.8 ± 34.8 pg/mg total protein in the discs with low-
grade degeneration (Pfirmann grade 2 to 3, n = 22), and
91.8 ± 47.9 pg/mg total protein in the discs with high
grade degeneration (Pfirmann grade 4 to 5, n = 7). Al-
though highly degenerated discs in the herniated group
had higher levels of NGF, no significant differences in
levels of NGF were found (P = 0.51; Figure 2). In the
non-herniated group, mean levels of NGF were 59.7 ±
21.6 pg/mg total protein in the discs with low-grade de-
generation (Pfirmann grade 3 to 4, n = 21), and 76.7 ±
32.0 pg/mg total protein in the discs with high-grade de-
generation (Pfirmann grade 5, n = 9). Similar to the her-
niated disc group, no significant differences in levels of
NGF were found between non-herniated discs with low-
grade degeneration and discs with high-grade degene-
ration (P = 0.10; Figure 3).
Correlation between NGF level and the presence of disc
herniation, age, sex, and the degree of disc degeneration
Pearson’s correlation analysis showed no significant cor-
relation between level of NGF and age. Spearman’s rank
correlation analysis showed significant correlation between
NGF and the presence of disc herniation (Spearman’s cor-
relation coefficient = − 0.311, P <0.05), but no significant
correlation between NGF and either sex or disc degene-
ration was found.
A multivariate analysis was performed, adjusted for
age and sex, with the presence of disc herniation and disc
degeneration as independent variables, and the NGF level
as the dependent variable. The results showed significant
correlation between the presence of disc herniation and
NGF levels (Additional file 1: Table S2; P = 0.019), how-
ever, no significant correlation was found between disc
Figure 1 Protein levels of nerve growth factor (NGF) measured using ELISA in herniated and non-herniated discs. Data from the ELISA
were normalized by total protein concentrations (pg/mg total protein). Mean values are indicated by short horizontal lines. The NGF level was
significantly higher in herniated discs. *P <0.05.
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P = 0.224).
Effects of disc levels of NGF on pre-operative and
postoperative symptoms
In the herniated group, pre-operative data obtained from
24 patients were compared between patients with low-
level NGF (n = 12) and high-level NGF (n = 12); no sig-
nificant difference was observed between the two groups
in any of the VAS scores, the ODI, or the detailed VAS
scores.
A year after surgery, postoperative data for the VAS
score, the ODI and the detailed VAS scores were collected.Figure 2 Protein levels of nerve growth factor (NGF, pg/mg total prot
indicated by short horizontal lines. No significant correlation was found beIn the herniated group, as already mentioned, only pa-
tients treated by decompression surgery were included for
the analysis of postoperative data (n = 17) of the 17 pa-
tients 14 were followed up at 1 year after surgery, and in
the remaining 3 patients, postoperative data collected at 6
months after the surgery were used. All of the VAS scores,
the ODI and the detailed VAS scores showed significant
improvement after surgery. In the low-level NGF group,
the postoperative VAS for LBP showed a non-significant
tendency toward greater residual LBP than in the high-
level NGF group (P = 0.064, Additional file 1: Table S3). In
the low-level NGF group, the postoperative VAS scores for
lower extremity pain and LBP in motion were significantlyein) measured using ELISA in herniated discs. Mean values are
tween NGF levels and the grade of disc degeneration (Pfirmann grade).
Figure 3 Protein levels of nerve growth factor (NGF, pg/mg total protein) measured using ELISA in non-herniated discs. Mean values
are indicated by short horizontal lines. No significant correlation was found between NGF levels and the grade of disc degeneration
(Pfirmann grade).
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file 1: Table S3).
In the non-herniated group, pre-operative data ob-
tained from 12 patients were compared between patients
in the low-level NGF group (n = 6) and the high-level
NGF group (n = 6); again, no significant differences were
observed between the two groups in any of the VAS
scores, the ODI or the detailed VAS scores (Additional
file 1: Table S4). All 12 patients were treated by fusion
surgery and evaluated at 1 year after surgery; none of
the postoperative data showed a significant difference
between the two groups (Additional file 1: Table S4).
Discussion
Previous studies using immunohistochemistry show the
expression of NGF in microvascular blood vessels [26],
and chondrocyte-like cells [27,31] in human intervertebral
discs. The presence of NGF-sensitive sensory fibers in hu-
man symptomatic discs has also been reported [20,26].
These findings suggest that NGF may regulate nerve in-
growth into degenerated discs. Considering that NGF has
the potential to sensitize sensory neurons [32,33], as
well as to promote axonal growth [34,35], NGF ex-
pressed in human discs may initiate the development of
discogenic pain.
This study reports that herniated intervertebral discs
show increased protein levels of NGF, which may lead to
pathological nerve ingrowth into the disc [35,36]. It has
been suggested that nerve ingrowth may be triggered by
annular rupture [10,11,16]. It is believed that nerve fi-
bers hardly extend into the normal disc without annular
rupture or disc degeneration because of the tight colla-
gen network of the uninjured annulus and the presenceof disc aggrecan, which has an inhibiting effect on ex-
tending nerve fibers [37]. However, destruction of the
annulus and increased NGF following disc herniation
(annular rupture) may give sensory nerve fibers an op-
portunity to extend further into the disc.
Lee et al. reported the results of their experiment that
determined the expression of NGF in the disc was sig-
nificantly higher in degenerative disc disease than in disc
herniation [38]. They examined the expression of NGF
using western blot analysis, whereas we used ELISA.
The mean age of the 10 patients enrolled in their study
as the degenerated disc disease group was 53.4 ± 8.8
years, whereas the mean age of the non-herniated group
in our study was 72.0 ± 10.0 years. Moreover, all 10 pa-
tients in their study were female, whereas 9 of the 30 pa-
tients in the non-herniated group of our study were
male. Differences in timing of surgery and indications
for surgery might also explain the different results. In
our study, we evaluated the correlation between NGF
levels and the presence of disc herniation after adjusting
for age, sex and the degree of disc degeneration, and this
analysis showed significant correlation. From these ob-
servations, we believe our results are more reliable and
conclude that in most cases NGF increased in the herni-
ated discs. However, as shown in Figure 1, some of the
herniated discs had low NGF levels compared with non-
herniated discs. There is a possibility that other factors
influencing NGF level in the disc will be found by future
studies.
The present study has several limitations. First, the cells
expressing NGF were not identified. Previous studies have
reported that various cells, such as chondrocyte-like cells
[27,31], blood vessels [26], and inflammatory cells [39],
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the fact that protein levels of NGF were increased in rup-
tured discs, because NGF may act as a pain generator re-
gardless of which cells express NGF in the disc. Second,
annular rupture frequently occurs during natural degen-
erative processes [40,41], suggesting discs from the non-
herniated group may also have annular rupture. Because
of this issue, data interpretation is complicated. However,
in our study, most annular ruptures in non-herniated discs
may have been in the chronic phase, whereas annular rup-
tures in herniated discs were mostly in acute or sub-acute
phases. Moreover, significant differences in NGF levels
were found between herniated and non-herniated discs,
though there is a possibility that a certain number of non-
herniated discs may have acute or sub-acute annular
ruptures. From these observations, we believe the se-
cond limitation is not a critical issue influencing our
conclusions.
The correlation between NGF expression and disc de-
generation is not clear cut. Purmessur et al., using im-
munohistochemistry, showed no significant difference in
the expression of NGF between non-degenerated and
degenerated discs [27]. Richardson et al., using quantita-
tive real-time polymerase chain reaction, described the
increased expression of NGF mRNA in the symptoma-
tic degenerated human intervertebral disc [28]. In our
study, no significant difference in NGF levels was de-
tected between low-grade and high-grade degenerated
discs, however, for the non-herniated group the P-value
(P = 0.10) was relatively low for analysis of NGF levels
and disc degeneration. Therefore, we further evaluated
the correlation between NGF levels and disc degener-
ation after adjusting for age and sex, and there was no
significant correlation (P = 0.224). From these results we
could at least exclude strong correlation between NGF
levels and disc degeneration. However, correlation be-
tween disc degeneration and NGF levels is still open to
question and further investigation is needed to reach a
conclusion.
The strong point of the present study is that any cor-
relation between NGF and clinical symptoms, both pre-
operative and postoperative, was thoroughly analyzed.
No significant differences in pre-operative symptoms
were found between high-level NGF and low-level NGF
groups in either the herniated or non-herniated groups.
However, in the herniated group, post-operative LBP
was lower in the patients with high levels of NGF in the
disc. Interestingly, our original detailed VAS scoring sys-
tem for LBP in motion, standing and sitting successfully
detected a significant difference in postoperative LBP in
motion between the high-NGF group and the low-NGF
group. These results lead us to conclude that NGF pro-
duced in the herniated discs may at least to some degree
be related to the LBP of these patients.The high-level NGF group also had more improve-
ment in lower extremity pain. The cause of lower ex-
tremity pain in disc herniation is generally recognized to
be a result of mechanical compression, as well as inflam-
mation [42,43]. It is also generally known that the herni-
ated disc contains various inflammatory mediators, such
as IL-1β, IL-6, and TNF-α [44-46]. As previously men-
tioned, NGF plays an important role in the generation of
inflammatory pain, and is regulated by other inflamma-
tory mediators [21-23]. Thus, a possible explanation for
these results is that inflammatory pain, in which NGF is
involved, is more intensely related to pre-operative lower
extremity pain in the high-level NGF group. In such pa-
tients, the inflammatory pain, which may be mainly re-
lated to LBP in motion and lower extremity pain, may
dramatically improve after removal of the herniated tis-
sue containing NGF.
In 2010, Lane et al. reported the results of a random-
ized trial of 450 patients with osteoarthritis of the knee;
the authors concluded that anti-NGF treatment pro-
duced significant reduction in pain [47]. A more recent
clinical study demonstrated the favorable effects of anti-
NGF treatment on chronic low back pain patients [48].
Kumar et al. suggested the existence of responders
and non responders to anti-NGF treatment, and that
the difference in response may be due to pretreat-
ment NGF levels [49]. From these observations, we
propose that our results may explain the different re-
sponse to anti-NGF therapy, in that the degree of func-
tional involvement of NGF in pain generation varied
among individuals.
In the non-herniated group, no significant difference
between the high-level and low-level NGF groups was
found in any of the postoperative symptom data. Be-
cause these patients were treated by fusion surgery and
mechanical stress to the symptomatic disc was com-
pletely eliminated, we believe that the pain derived from
the disc was completely resolved irrespective of NGF
levels. Thus, in the non-herniated group, it seems rea-
sonable that postoperative symptoms in the high-level
NGF group were similar to those of the low-level NGF
group. This suggests that postoperative pain after fusion
surgery may be due to factors other than surgery to
the disc.
Our study found no significant differences in pre-
operative LBP between the herniated and non-herniated
groups, and does not prove the hypothesis that NGF up-
regulation persists in the disc to cause chronic disco-
genic LBP. However, a limitation of our study is that the
subjects’ back pain was not necessarily caused by disc
herniation or disc degeneration. Future studies in which
inclusion criterion are strictly limited to patients with
discogenic pain are expected to elucidate the correlation
between NGF and back pain in these patients.
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Because numerous studies support the important role of
NGF in the generation of discogenic pain, the results of
the present study raise the possibility that NGF pro-
duced following annular rupture may, at least in some
cases, initiate the development of discogenic back pain.
We have to keep in mind that most annular ruptures do
not necessarily cause chronic discogenic LBP [40,41].
However, chronic discogenic LBP develops when patho-
logical changes, such as nerve ingrowth and sensitiza-
tion, are induced by NGF produced following annular
rupture. Our results showing that pre-operative disc
protein levels of NGF affect postoperative LBP and lower
extremity pain, suggest there is some degree of impact
of NGF on generation of LBP and lower extremity pain
that varies among individual patients.
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